SIERRA clinical trial dosimetry results support low dose anti-CD45 iodine (131I) apamistamab [Iomab-B] for targeted lymphodepletion prior to adoptive cell therapy Meeting Abstract
| Authors: | Nath, R.; Geoghegan, E. M.; Ulrickson, M. L.; Spross, J. A.; Lichtenstein, R. H.; Konerth, S.; Fisher, D. R.; Liang, Q.; Ludwig, D.; Reddy, V.; Berger, M. S.; Gyurkocza, B. |
| Abstract Title: | SIERRA clinical trial dosimetry results support low dose anti-CD45 iodine (131I) apamistamab [Iomab-B] for targeted lymphodepletion prior to adoptive cell therapy |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160403231 |
| DOI: | 10.1182/blood-2019-128838 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1958 -- Source: Wos |
